InvestSMART

Aroa Biosurgery Limited (ASX: ARX) - Announcements

Current share price for ARX : $0.550 0.005 (0.90%)+

ASX company news and announcements for Aroa Biosurgery Limited (ARX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Aroa Biosurgery Limited (ARX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Aroa Biosurgery Limited (ARX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Aroa Biosurgery Limited (ARX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$190 FY25 Appendix 4E and Full Year Results 29 May 2025 8:39AM $0.470 $0.550 risen by 17.02%
$190 Notification of Full Year Results Webinar - New Date 13 May 2025 3:57PM $0.460 $0.550 risen by 19.57%
$190 Initial substantial shareholding from AEF 1 May 2025 9:39AM $0.440 $0.550 risen by 25%
$190 Investor Presentation 29 Apr 2025 9:15AM $0.420 $0.550 risen by 30.95%
$190 March 2025 Quarterly Report and Appendix 4C 29 Apr 2025 8:45AM $0.420 $0.550 risen by 30.95%
$190 Notification of Quarterly Results Webinar 22 Apr 2025 9:45AM $0.405 $0.550 risen by 35.80%
$190 Notification of cessation of securities - ARX 14 Apr 2025 2:50PM $0.420 $0.550 risen by 30.95%
$190 Investor Presentation 29 Jan 2025 8:57AM $0.800 $0.550 fallen by 31.25%
$190 December 2024 Quarterly Report and Appendix 4C 29 Jan 2025 8:54AM $0.800 $0.550 fallen by 31.25%
$190 Notification of Quarterly Results Webinar 22 Jan 2025 2:02PM $0.745 $0.550 fallen by 26.17%
$190 Notification regarding unquoted securities - ARX 7 Jan 2025 12:16PM $0.750 $0.550 fallen by 26.67%
$190 Aroa Incentive Plan 6 Jan 2025 4:21PM $0.750 $0.550 fallen by 26.67%
$190 ARX First Clinical Evidence from MASTRR Study Published 23 Dec 2024 8:53AM $0.680 $0.550 fallen by 19.12%
$190 Aroa Half Year Results Presentation 26 Nov 2024 8:45AM $0.650 $0.550 fallen by 15.38%
$190 Aroa Biosurgery Half Yearly Results H1 FY25 26 Nov 2024 8:39AM $0.650 $0.550 fallen by 15.38%
$190 Appendix 4D and Half Year Report 26 Nov 2024 8:38AM $0.650 $0.550 fallen by 15.38%
$190 Notification of Half Year Results Webinar 19 Nov 2024 11:46AM $0.630 $0.550 fallen by 12.70%
$190 Investor Presentation 22 Oct 2024 8:45AM $0.520 $0.550 risen by 5.77%
$190 September 2024 Quarterly Report and Appendix 4C 22 Oct 2024 8:43AM $0.520 $0.550 risen by 5.77%
$190 Notification of Quarterly Results Webinar 15 Oct 2024 8:56AM $0.525 $0.550 risen by 4.76%
$190 Notification of cessation of securities - ARX 11 Oct 2024 10:36AM $0.545 $0.550 risen by 0.92%
$190 Change of Director's Interest Notice - CM 4 Oct 2024 4:06PM $0.530 $0.550 risen by 3.77%
$190 Change in substantial holding 27 Aug 2024 4:26PM $0.470 $0.550 risen by 17.02%
$190 Change in substantial holding 26 Aug 2024 3:07PM $0.485 $0.550 risen by 13.40%
$190 Change of Director's Interest Notice - DH 23 Aug 2024 4:01PM $0.453 $0.550 risen by 21.55%

76 - 100 of 764 results

Page 4 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.